Transcytosis (also known as cytopempsis) is a type of transcellular transport in which various macromolecules are transported across the interior of a cell. Macromolecules are captured in vesicles on one side of the cell, drawn across the cell, and ejected on the other side. Examples of macromolecules transported include IgA, transferrin, and insulin. While transcytosis is most commonly observed in epithelial cells, the process is also present elsewhere. Blood capillaries are a well-known site for transcytosis, though it occurs in other cells, including neurons, osteoclasts and M cells of the intestine.
National Research Council of Canada
National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.
Solar cell
Biomedicine
Biotechnology
Oncology drugs
Phosphatase
Kinase
Alzheimer's disease
Building-integrated photovoltaics
Cell encapsulation
Antibody-drug conjugate
Photovoltaics
Enzyme
Coronavirus disease 2019 (COVID-19)
Pharmaceutics
Aptamer
Biomedical engineering
Drug design
Cancer research
Toxicology
Biocompatible material
Regents of the University of California
The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).
Pathology
Companion diagnostic
Applied Molecular Transport, Inc.
http://www.appliedmt.com
|
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood on November 21, 2016 and is headquartered in South San Francisco, CA.
Molecular Transport
Biomedicine
Biotechnology
Biopharmaceutical
Gastrointestinal agent
Immunotherapy
Biophysics
Monoclonal antibody
Bionics
Blood cell
Cell signaling
Exosome
Clinical trial
EnGeneIC Molecular Delivery Pty Ltd.
Trinity Biosystems, Inc.
http://www.trinitybiosystems.com
|
Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA.
Medicine
Pharmacy and Therapeutics
Mucosal epithelium
Transport Pathway
Macromolecule
Therapeutic protein
Physiology
Payload
AriZeke Pharmaceuticals, Inc.
AriZeke Pharmaceuticals, Inc. delivers therapeutic proteins and genes. The company's products are used in treatment of disorders which are caused by various bacteria. It is located in San Diego, CA.
Pharmacy
Therapeutic protein
Gene
Botanical drug
Herb
Insilico Co. Ltd.
http://www.insilico.co.kr
|
Insilico Co. Ltd. develops information technology and material fusion technology platform. Its business areas include information technology solution, smart materials and consulting services. The firm offers research information management, simulation, regulation, quality management solutions. The company was founded on November 27, 2002 and is headquartered in Seongnam, South Korea.
Software
Enterprise software
Smart material
Information management
Simulation
Andaris Ltd.
http://andaris.tuxfamily.org
|
Andaris is a script that is designed to allow internet users maximum browser and web browsing performance.
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
Software development
Gabapentin enacarbil
Neurological disorder
Psoriasis
Clobazam
Gabapentin
Biopharmaceutical
Phenibut
Parkinson's disease
GABA receptor agonist
Multiple sclerosis
Zaleplon
Eszopiclone
Acamprosate
Neurotransmitter
Zolpidem
Baclofen
Antihistamine
Apomorphine
Safinamide
Quadrant Healthcare Ltd.
http://www.quadrant.co.uk
|
Quadrant Healthcare Ltd., a subsidiary of Philip Morris International, Inc., is a company headquartered in Chippenham, UK, that functions as an investment holding company. It was founded in 1995.
Epicyte Pharmaceutical, Inc.
Epicyte Pharmaceutical, Inc., part of Biolex Therapeutics, Inc., is a company headquartered in San Diego, CA, that develops biopharmaceuticals. The firm was founded by Mich B. Hein. Biolex Therapeutics, Inc. acquired Epicyte Pharmaceutical, Inc. on May 06, 2004.
Monoclonal antibody
Pharmacy and Therapeutics
Seoul National University Bundang Hospital
Seoul National University Bundang Hospital (분당 서울대병원) is located in Gumi-dong, Bundang, Seongnam, Gyeonggi-do, South Korea. It began its first treatment on 10 May 2003. It was set up due to a rapid increase in demand for geriatric treatment and the government's request for the establishment of a medical facility for local residents.
Emergency department
Biological membrane
3D bioprinting
Transcriptome
microRNA
Genomic medicine
Newborn screening
Molecular medicine
Biocompatible material
Cardiovascular agent
Tissue engineering
Personalized medicine
Data analysis
CRISPR
Genome
Genomics
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline.
The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche.
Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.
Biotechnology
Biology
Medicine
Bevacizumab
Oncology drugs
Monoclonal antibody
Drug discovery
Rituximab
Immunotherapy
Biopharmaceutical
Cancer immunotherapy
Cisplatin
Paclitaxel
Pharmaceutical manufacturing
Genomics
Carboplatin
Cardiovascular agent
Biomedicine
Tocilizumab
Ixabepilone
Kenneth S. Warren Institute
The Kenneth S. Warren Institute is a not-for-profit organization based in Durham, North Carolina that as of 2017 appears to be defunct. It had been based in Tarrytown, New York, and in 2001, the institute bought a 15-acre (61,000 m²) campus located in Westchester County, New York from the Kitchawan Institute. At that time its director and lead researcher was Anthony Cerami, and it was a medical research institute that had been doing research related to erythropoietin derivatives they called "tissue protective cytokines". They also said that they coordinated with researchers who were working on vaccines for neglected tropical diseases. Cerami has been president and trustee of an organization called the "Kenneth S. Warren Laboratories, Inc." as of March 1998.
Neglected tropical diseases
Medical research
Tropical disease
Erythropoietin
Kunshan Xinyunda Biotechnology Co., Ltd.
Kunshan Xinyunda Biotechnology Co., Ltd., established on 2018-01-30, Business scope includes technology development in the field of biotechnology,technical consulting,Technical Services;Medical Research and Experimental Development(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)
Aptamer Sciences, Inc. 1 Founded in April 2011 by the best aptamer experts in Korea under the banner of bio company.
Based on the globally competitive Aptamer Technology Platform, they are an R & D-based bio venture company that develops innovative therapeutics and diagnostic technologies that are difficult to develop with protein and genome-based biomaterials. Comprehensive range of pressures from technology to effectively discover high-performance aptamers, to improve and optimize the found aptamers for application purposes, and to develop innovative aptamer new drugs and aptamer-based multi-index diagnostic technology. They are building a tamer technology platform.
Aptamer
Pharmacy and Therapeutics
Drug discovery
Aptamer Technology
The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community.
The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.
Occupational therapy
Association (object-oriented programming)
Pharmacy
Medicine
Infusion pump
Breast pump
Vaginal ring
Intrauterine device
Uterus
Breast cancer
Reproductive health
Biology
Computer science
Fertility
Internal medicine
Implantable infusion pumps
Cell therapy
Neurotechnology
Neurorehabilitation
Breast ultrasound
Seoul National University Hospital
Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).
Emergency department
Telemetry
Antigen-presenting cell
Investigational device exemption
Natural killer cell
Respiratory monitoring
Apomorphine
Safinamide
Travatan Z
Maternal-fetal medicine
Family planning
Prenatal care
Neonatology
Levodopa
Medical robot
Obstetrics
Active ingredient
Gynecology
People also interested in
Computer scienceSimulationInternal medicinePathologyBiophysicsBiomedicinePhosphataseClinical trialExosomeCell therapy